Purchase

Recombinant Human LILRA5/CD85f protein (rFc Tag) (HPLC verified)

Species

Human

Purity

>90 %, SDS-PAGE
>90 %, SEC-HPLC

Tag

rFc Tag

Activity

not tested

Cat no : Eg2737


Product Information

Purity >90 %, SDS-PAGE
>90 %, SEC-HPLC
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human LILRA5 protein Gly42-Arg268 (Accession# A6NI73-1) with a rabbit IgG Fc tag at the C-terminus.
GeneID 353514
Accession A6NI73-1
PredictedSize 51.3 kDa
SDS-PAGE 55-65 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

LILRA5 (Leukocyte immunoglobulin-like receptor A5) belongs to a family of receptors known to regulate leukocyte activation. The transmembrane forms of LILRA5 contain a short cytoplasmic domain and a charged arginine residue within the transmembrane region that is likely to mediate its association with a yet-to-be identified ITAM-containing adaptor protein.LILRA5 is mostly expressed by monocytes and neutrophils.

References:

1. Ainslie Mitchell. et al. (2008). Eur J Immunol. 38(12):3459-3473. 2. Luis Borges. et al. (2003). Blood. 101(4):1484-1486.